精品文档---下载后可任意编辑2024 年经验性使用抗生素治疗血液病患者院内感染疗效分析的开题报告【摘要】血液病患者因为疾病本身或治疗过程中免疫功能的降低而容易发生院内感染，其中菌血症是最常见的院内感染之一。抗生素是治疗院内感染的基本药物，但随着抗生素的广泛使用，药物抗性问题越来越突出，因此在抗生素的使用中应该更加注意药物的选择和合理使用，以提高治疗效果。本文旨在分析经验性使用抗生素治疗血液病患者院内感染的疗效，探讨其优缺点、药物选择和应用策略。选择 2024 年到 2024 年在本院住院的血液病患者中，因院内感染接受过经验性抗生素治疗的患者共计215 例，进行回顾性资料的分析与总结。讨论结果显示，本次经验性使用抗生素治疗血液病患者院内感染的疗效整体较好，经验性使用的抗生素种类以 β 内酰胺类药物和氨基糖苷类药物最为常见，其中以头孢哌酮/舒巴坦、亚胺培南/西司他丁、庆大霉素等药物疗效最佳。但在抗生素治疗中仍存在治疗失败与用药不法律规范的问题，因此需进一步加强抗生素的临床应用和管理，提高患者治疗效果和预后情况。【关键词】血液病；院内感染；抗生素；治疗效果【Abstract】Patients with hematological diseases are prone to nosocomial infections due to the disease itself or the decrease of immunity during the treatment process, among which bacteremia is one of the most common nosocomial infections. Antibiotics are the basic drugs for treating nosocomial infections, but with the widespread use of antibiotics, the problem of drug resistance is becoming increasingly prominent. Therefore, the selection and rational use of drugs should be paid more attention to improve the treatment effect.The purpose of this study was to analyze the efficacy of empirical antibiotic treatment for nosocomial infections in patients with hematological diseases, and to explore its advantages and disadvantages, drug selection and application strategies. A total of 215 patients who received empirical antibiotic treatment for nosocomial infections from 2024 to 精品文档---下载后可任意编辑2024 were ...
